Here are key facts for
USMLE Step 2 & COMLEX-USA Level 2 from the
Cardiomyopathies tutorial, as well as points of interest at the end of this document that are not directly addressed in this tutorial but should help you prepare for the boards. See the
tutorial notes for further details and relevant links.
Dilated Cardiomyopathy (DCM)
1. Presents with
biventricular heart failure: dyspnea, orthopnea, PND, edema, fatigue.
2. Most common form of cardiomyopathy; often due to
idiopathic,
ischemic, or
toxic causes (alcohol, doxorubicin).
3.
Echocardiogram shows
dilated LV with
reduced EF (<40%) and hypokinesis.
4.
S3 heart sound is often present due to volume overload.
5. Treatment follows standard
HFrEF (heart failure with reduced EF) protocols:
- ACE inhibitors or ARBs
- Beta-blockers (carvedilol, metoprolol succinate, bisoprolol)
- Loop diuretics (symptom relief)
- Spironolactone, SGLT2 inhibitors, hydralazine/nitrates as indicated
6. Consider
ICD placement if EF remains <35% despite medical therapy.
7.
Cardiac transplant for refractory cases.
Hypertrophic Cardiomyopathy (HCM / HOCM)
1. Presents in young adults with
exertional syncope, dyspnea, or chest pain.
2.
Systolic ejection murmur best heard at the left lower sternal border, louder with Valsalva or standing.
3. Caused by
autosomal dominant sarcomere gene mutations.
4. Diagnosis:
Echocardiogram shows
asymmetric septal hypertrophy with possible
systolic anterior motion (SAM) of mitral valve.
5. First-line treatment is
beta-blockers (or verapamil if contraindicated) to increase diastolic filling time.
6.
Avoid preload-reducing agents (e.g., diuretics, nitrates, vasodilators).
7.
ICD placement for high-risk features (family history of sudden death, unexplained syncope, severe LVH >30 mm, VT on Holter).
8. Patients should
avoid competitive sports and
dehydration.
Restrictive Cardiomyopathy (RCM)
1. Presents with
right-sided heart failure symptoms: peripheral edema, hepatomegaly, ascites.
2. LV function and EF are typically preserved;
diastolic dysfunction is key.
3. Causes include
amyloidosis,
hemochromatosis,
sarcoidosis,
radiation, and
fibrosis.
4. ECG may show
low-voltage QRS (especially in amyloidosis).
5.
Echocardiogram shows normal-sized ventricles with
biatrial enlargement and diastolic dysfunction.
6. In
amyloidosis, confirm diagnosis with
abdominal fat pad biopsy or
cardiac MRI.
7. Treatment is
cause-specific; consider
diuretics cautiously (preload dependent).
Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
1. Presents with
ventricular arrhythmias, palpitations, syncope, and sudden cardiac death.
2. Common in young adults, especially
athletes.
3. Diagnosis via
MRI, ECG (epsilon waves), and family history.
4. Managed with
activity restriction,
ICD placement, and
antiarrhythmics.
Dilated Cardiomyopathy (DCM)
1. Can be secondary to
myocarditis (e.g., viral, post-COVID, autoimmune).
2.
Alcoholic cardiomyopathy may reverse with abstinence.
3. DCM due to
chemotherapy (e.g., doxorubicin) is dose-related and cumulative.
4. Consider
peripartum cardiomyopathy in postpartum women with new-onset heart failure.
5.
Chagas disease is an endemic cause of DCM in Latin America.
Hypertrophic Cardiomyopathy (HCM / HOCM)
1. Murmur intensity changes with
preload/afterload maneuvers is a classic physical exam test item.
2.
Positive family history should prompt evaluation of first-degree relatives.
3. Patients with HCM and arrhythmias or risk factors should be evaluated for
ICD candidacy.
4.
Apical variant HCM (Yamaguchi type) more common in some Asian populations.
Restrictive Cardiomyopathy (RCM)
1. May mimic
constrictive pericarditis, but pericarditis has pericardial knock and pericardial thickening on imaging.
2. Consider
hemochromatosis with signs of liver disease and diabetes.
3. Consider
sarcoidosis in patients with systemic granulomatous disease or AV block.
Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
1. May present with
T wave inversions in V1–V3 and
epsilon waves.
2. Often diagnosed using the
Task Force Criteria: family history, ECG, MRI, biopsy, and arrhythmia findings.
Below is information not explicitly contained within the tutorial but important for USMLE & COMLEX 2.
Dilated Cardiomyopathy
1.
LV thrombus is a known complication; anticoagulation may be indicated in high-risk patients.
2. In
end-stage DCM, consider
advanced therapies like LVAD or transplant.
Hypertrophic Cardiomyopathy
1. Sudden death in athletes is most often due to HCM;
screening athletes is controversial but high-yield.
2.
Phenylephrine (increased afterload) may be used acutely to
reduce obstruction during hypotensive crises.
Restrictive Cardiomyopathy
1. In
amyloidosis, a
speckled or granular myocardium may be seen on echo.
2. Cardiac MRI helps distinguish infiltrative from non-infiltrative cardiomyopathy.
General Clinical Integration
1. On Step 2,
distinguishing among cardiomyopathies is often done using clinical vignettes involving
exercise intolerance, murmurs, heart sounds, and echocardiogram findings.
2. Know the
initial step,
most accurate test, and
next best step in management for each condition.